Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857576 | PMC |
| http://dx.doi.org/10.1016/j.abd.2019.09.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
S2k guideline: Laser therapy of the skin.
J Dtsch Dermatol Ges
September 2022
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Dermatology, Venereology and Allergology, Division of Evidence-Based Medicine (dEBM), Berlin.
Article Synopsis
- This guideline focuses on enhancing the safety and effectiveness of laser treatments for various skin lesions, particularly emphasizing caution in treating lesions with higher melanocyte levels.
- It advises against the use of laser therapy for pigmented melanocytic nevi and provides specific recommendations for conditions like lentigines, café-au-lait spots, non-pigmented dermal nevi, and melasma among others.
- Additionally, the guideline addresses treatments for a wide range of skin issues, including inflammatory dermatoses, wrinkles, scars, benign growths, and different types of vascular and viral lesions.
Neurofibromatosis and vitiligo: A simple coincidence or coexistence?
Int J Rheum Dis
April 2022
Department of Dermatology, Farhat Hached University Hospital, University of Medicine, Sousse, Tunisia.
[Analysis of genetic variant in a case of sporadic neurofibromatosis type I with alopecia areata and vitiligo].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
November 2021
Department of Dermatology, the First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, China.
Objective: To explore the genetic basis for a patient with clinically suspected neurofibromatosis type I, alopecia areata and vitiligo.
Methods: Variant of the NF1 gene was detected by chip capture and high-throughput sequencing. Candidate variant was verified by Sanger sequencing of the family trio.
Cutaneous manifestations in neurofibromatosis type 1.
Clin Ter
November 2020
Dermatologic Clinic, "Sapienza" University of Rome, Rome.
Article Synopsis
- The study aimed to assess the prevalence of skin manifestations in patients with Neurofibromatosis type 1 (NF1) over a span of nearly 37 years at a university in Italy.
- Out of 1102 NF1 patients reviewed, the majority exhibited café-au-lait macules (96.5%), axillary and inguinal freckling (90%), and neurofibromas (78.1%).
- The findings highlight that NF1 is a complex disorder with a wide range of skin issues, demonstrating considerable variability in manifestations among individuals, even within the same family.
Neurofibromatosis with vitiligo: an uncommon association rather than coexistence?
An Bras Dermatol
December 2019
Dermatology Department, PGIMER& Dr. Ram Manohar Lohia Hospital, New Delhi, India.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!